Dr Reddy’s with Russian Direct Investment Fund will soon be launching the Sputnik-V vaccine following the recent approval for emergency use by Indian authorities.
Expectations of such launches from Cadila and Aurobindo, too, have increased significantly.To be sure, vaccine makers Serum Institute of India Pvt.
Ltd and Bharat Biotech Ltd have the early-mover advantage with their respective vaccines already in use.That said, the sheer size of the country’s population that needs to be inoculated is enough to tender a huge opportunity for every company.Analysts at BofA Securities India Ltd said 34-48% of the population will be inoculated in 2021.